EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES

We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy pe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: N. L. Deineko, T. I. Bulycheva, A. M. Kovrigina, A. A. Grigoriyv
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f50
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ce932ee077a94ad58176c23dd09c4f50
record_format dspace
spelling oai:doaj.org-article:ce932ee077a94ad58176c23dd09c4f502021-11-18T08:03:44ZEXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES1563-06252313-741X10.15789/1563-0625-2014-5-437-442https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f502014-11-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/730https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XWe have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy people,using a method of immunocytochemical staining and indirect immunofluorescence technique. It was found that in cases of lymphoproliferative diseases with low proliferation rates, as based on the numbers of Ki-67 positive cells, as well as in non-malignant blood diseases, the A3 antigen was localized in nucleoli, and it was visualized as focal fluorescence. In malignant lymphoproliferative diseases with high proliferation indexes, the number of brightly fluorescent foci is observed, with formation of necklace-like structures within the nucleolar structures. The obtained data point to a diagnostic significance of A3 Mab in assessment of cellular proliferative rates in patients with various lymphoproliferative diseases. It was established that, in contrast to Ki-67, the proliferation stage could be determined for each cell, according to the number of fuorescent foci in nucleoli. This specific property of the A3 antigen points to its significance for diagnostics and malignancy staging of lymphoproliferative disorders.N. L. DeinekoT. I. BulychevaA. M. KovriginaA. A. GrigoriyvSPb RAACIarticleantigen a3lymphoproliferative diseasesnucleoliimmunocytochemistryImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 16, Iss 5, Pp 437-442 (2014)
institution DOAJ
collection DOAJ
language RU
topic antigen a3
lymphoproliferative diseases
nucleoli
immunocytochemistry
Immunologic diseases. Allergy
RC581-607
spellingShingle antigen a3
lymphoproliferative diseases
nucleoli
immunocytochemistry
Immunologic diseases. Allergy
RC581-607
N. L. Deineko
T. I. Bulycheva
A. M. Kovrigina
A. A. Grigoriyv
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
description We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy people,using a method of immunocytochemical staining and indirect immunofluorescence technique. It was found that in cases of lymphoproliferative diseases with low proliferation rates, as based on the numbers of Ki-67 positive cells, as well as in non-malignant blood diseases, the A3 antigen was localized in nucleoli, and it was visualized as focal fluorescence. In malignant lymphoproliferative diseases with high proliferation indexes, the number of brightly fluorescent foci is observed, with formation of necklace-like structures within the nucleolar structures. The obtained data point to a diagnostic significance of A3 Mab in assessment of cellular proliferative rates in patients with various lymphoproliferative diseases. It was established that, in contrast to Ki-67, the proliferation stage could be determined for each cell, according to the number of fuorescent foci in nucleoli. This specific property of the A3 antigen points to its significance for diagnostics and malignancy staging of lymphoproliferative disorders.
format article
author N. L. Deineko
T. I. Bulycheva
A. M. Kovrigina
A. A. Grigoriyv
author_facet N. L. Deineko
T. I. Bulycheva
A. M. Kovrigina
A. A. Grigoriyv
author_sort N. L. Deineko
title EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
title_short EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
title_full EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
title_fullStr EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
title_full_unstemmed EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
title_sort expression of a new a3 antigen in the cells of patients with various lymphoproliferative diseases
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/ce932ee077a94ad58176c23dd09c4f50
work_keys_str_mv AT nldeineko expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases
AT tibulycheva expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases
AT amkovrigina expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases
AT aagrigoriyv expressionofanewa3antigeninthecellsofpatientswithvariouslymphoproliferativediseases
_version_ 1718422447858909184